No retraction, correction or concern found when last checked on Oct 26, 2026.
Iron Storage within Dopamine Neurovesicles Revealed by Chemical Nano-Imaging
Richard Ortega, Peter Cloetens, Guillaume Devès and 2 more (opens in a new tab)
PLoS ONE · 2007
doi:10.1371/journal.pone.0000925 (opens in a new tab)
Abstract
Altered homeostasis of metal ions is suspected to play a critical role in neurodegeneration. However, the lack of analytical technique with sufficient spatial resolution prevents the investigation of metals distribution in neurons. An original experimental setup was developed to perform chemical element imaging with a 90 nm spatial resolution using synchrotron-based X-ray fluorescence. This unique spatial resolution, combined to a high brightness, enables chemical element imaging in subcellular compartments. We investigated the distribution of iron in dopamine producing neurons because iron-dopamine compounds are suspected to be formed but have yet never been observed in cells. The study shows that iron accumulates into dopamine neurovesicles. In addition, the inhibition of dopamine synthesis results in a decreased vesicular storage of iron. These results indicate a new physiological role for dopamine in iron buffering within normal dopamine producing cells. This system could be at fault in Parkinson's disease which is characterized by an increased level of iron in the substantia nigra pars compacta and an impaired storage of dopamine due to the disruption of vesicular trafficking. The re-distribution of highly reactive dopamine-iron complexes outside neurovesicles would result in an enhanced death of dopaminergic neurons.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 26, 2026. Paragraph numbers are ours, so an answer can point at one.
Introduction
The complete understanding of what is the chemical basis of the neuron cells is a major challenge that requires the development of new single-cell analytical methods. For example, very little is known about the distribution of metal ions such as iron, zinc, or copper, in neurons at the subcelullar level. However, those chemical elements have essential regulatory functions and their disturbed homeostasis is involved in neurodegenerative diseases, such as Alzheimer's disease, Huntington's disease, or Parkinson's disease (PD). Anomalous iron handling has been proposed to be involved in the selective loss of dopaminergic neurons from the substancia nigra pars compact (SNpc) in PD,. Indeed, iron specific accumulation in the SNpc is associated with PD –. This phenomenon is still unexplained. The role of iron in the etiology of PD is also supported by pharmacological evidence; a number of iron chelators have been shown to attenuate PD symptoms in animal models,,, confirming that iron could either mediate or accentuate neurotoxicity. Because dopamine can form stable complexes with iron in vitro,, it has been suggested that dopamine may exert a protective effect by chelating iron in dopaminergic neurons and that this system might be at fault in PD. It is therefore theoretically possible that dopamine-iron complexes may exist in dopaminergic neurons but they have not yet been evidenced experimentally. The question then arises whether the dopamine-iron complex occurs in vivo and if so, where?
Chemical imaging is the simultaneous measurement of chemical information and spatial information. Up to now the lack of analytical techniques with sufficient spatial resolution and detection sensitivity prevented the study of iron distribution in neurons at the subcelullar level. We developed an original setup for high spatial resolution chemical imaging at the European Synchrotron Radiation Facility (Fig. 1A, B) with a 88 nm X-ray beam of very high flux (up to 1012 photons/s). This spatial resolution is ten times better than what was available up to now for hard X-ray chemical imaging. The characteristics of this unique nanoprobe fulfill the requirements for mapping biological trace element distributions at a size compatible with the analysis of most cellular compartments such as mitochondria, lysosomes, or neurosecretory vesicles. As exemplified in Figure 1, this newly developed synchrotron X-ray fluorescence nanoprobe is able to detect down to 10−18 g of Fe within a cellular structure as small as 100 nm diameter. The aim of this study was to elucidate the role of dopamine on iron homeostasis in dopaminergic cells by comparing dopamine and iron distributions in control dopaminergic cells and dopaminergic cells exposed to an inhibitor of dopamine synthesis. Using this chemical nano-imaging system we investigated the subcellular distribution of iron in dopamine producing neurons. PC12 rat pheocromocytoma cell line was used as in vitro model of dopamine producing cells,. PC12 neuronal cells were differentiated with NGF and exposed in vitro to sub-cytotoxic concentrations of iron and/or alpha-methyltyrosine (AMT), an inhibitor of tyrosine hydroxylase (TH), the rate limiting enzyme in the biosynthesis of dopamine.
Iron and dopamine distribution in dopamine producing cells
The iron profile distribution, as retrieved for example from the region zoomed in figure 1C, shows that iron is localized nearly exclusively in structures of typically 200 nm in size. Iron rich structures are not always resolved by the beam and clusters of larger dimension are also observed. These structures are found in the cytosol (Fig. 2), neurite outgrowths (Fig. 3), and distal ends (Fig. 4) of dopamine producing PC12 cells. The combination of dopamine fluorescence microscopy and synchrotron X-ray chemical nano-imaging reveals the co-localization of iron and dopamine in dopamine neurovesicles (Fig. 5C, D). A blue fluorescence was observed, only for cells exposed to an excess of iron, which corresponds to the reported fluorescence of oxidized forms of dopamine,. When control cells are compared to cells exposed to an excess of iron, the same subcellular distribution is found but with a higher number of iron-rich structures in iron-exposed cells (Fig. 2). The iron content is found particularly high in neurite outgrowths and distal ends of cells exposed to excess iron (Fig. 3 and 4). Using the multielemental capabilities of the synchrotron X-ray fluorescence nanoprobe we were also able to image the distribution of some other essential chemical elements such as potassium or zinc (Fig. 2 to 4). Contrary to what is observed for iron, potassium and zinc are ubiquitous in dopamine producing cells and not selectively distributed to dopamine neurovesicles.
Inhibition of dopamine synthesis
To confirm the interaction of dopamine and iron, PC12 cells were exposed to AMT an inhibitor of TH and consequently of dopamine synthesis. The inhibition of TH results in a decrease of the total iron content in PC12 cells (Fig. 6). The decrease of iron consecutive to AMT treatment was observed both in absence or presence of excess iron. It is interesting to note that AMT had no effect on the cellular concentration of zinc (Fig. 6), indicating that AMT affects selectively the distribution of iron. The decrease of iron concentration following AMT exposure alone is more pronounced in neuronal processes, neurite outgrowths and distal ends, than in cell bodies (Fig. 7). In cells exposed to AMT alone only a basal level of iron is detected with none or very few iron-rich structures (Fig. 2 to 4 and 7). Similarly, in cells exposed to iron and AMT, the number of iron-rich structures is lower than in cells exposed to iron alone, especially in neurite outgrowths and distal ends (Fig. 2 to 4 and 7).
Discussion
Dopamine is a neurotransmitter member of the catecholamine family. It is well established that the biosynthesis of dopamine takes place in the cytosol from which the neurotransmitter is transported through a specific transport system into presynaptic vesicles. The vesicular storage protects dopamine from degradation by the enzyme monoamine oxidase. In differentiated PC12 cells, dopamine is known to be stored within large dense core vesicles of 100–200 nm in the cytosol and neuronal processes (dendrites and axons), with greatest intensity at varicosities, branch points and distal ends,. This is exactly what we observed in this study using epifluorescence microscopy of dopamine distribution in PC12 cells (Fig. 5). These observations provide the first experimental evidence that iron and dopamine accumulate into dopamine vesicles of dopamine producing neurons.
Potassium shows an intracellular distribution proportional to cell volume (Fig. 2 to 4) as expected from the known ubiquitous distribution of this element in mammalian cells,. Similarly, zinc is ubiquitous within the cell volume, with slightly higher levels in the nucleus (Fig. 2 to 4). It is also well known that this essential trace element is involved in numerous protein functions in all cellular compartments, including zinc-finger transcription factors in the nucleus. Zinc does not co-localize with iron in dopamine neurovesicles which suggests a selective interaction between dopamine and iron.
It is interesting to note that AMT, an inhibitor of dopamine synthesis, had no effect on the cellular concentration of zinc (Fig. 6), indicating that AMT affects selectively the distribution of iron. The decrease of iron concentration following AMT exposure alone is more pronounced in neuronal processes, neurite outgrowths and distal ends, than in cell bodies (Fig. 7). Therefore, the inhibition of dopamine synthesis induces a decrease in total iron cellular content, specifically within dopamine vesicles. This result confirms the storage of iron in dopamine vesicles and also suggests a physiological role of dopamine in the control of iron homeostasis in dopaminergic cells.
The observation of a basal level of iron after inhibition of dopamine synthesis (Fig. 2 to 4 and 7) indicates that dopamine vesicles are not the only sites for iron storage. The iron storage protein ferritin is synthesized by PC12 cells, and ferritin molecules are known to be present in axons of neuronal cells. Redox metals such as iron do not appear free in solution to any extent in healthy living systems because of their highly toxic reactivity. Both systems, ferritin and dopamine, could contribute to iron storage in dopaminergic cells. In addition, it can be speculated that our observation of iron-dopamine structures in neurite outgrowths could also be related to the axonal transport of iron from the cytosol to the synapse,.
PD results from a shortage of dopamine in the brain induced by the selective death of dopamine producing neurons in the SNpc Dopaminergic neurons die in a slow but progressive manner leading to a depletion of dopamine in the striatum compromising the capacity of the brain to orchestrate voluntary movement. The causes of the selective death of SNpc dopaminergic neurons in PD are still largely unknown. Increasing evidence suggests that abnormal iron handling in the brain may be involved in PD etiology –. PD is both characterized by iron specific accumulation in the SNpc –, and by a decrease in TH protein content and TH mRNA in SNpc dopaminergic neurons relative to control subjects,. Our results suggest that the elevation of iron concentration in the SNpc, and the concomitant loss of TH hydroxylase activity, may lead to a lack of iron-dopamine binding capability rendering the dopaminergic neurons more prone to iron toxicity. It has been also suggested that mutations in α-synuclein, a protein mutated in some familial forms of PD, could result in a reduced number of vesicles being available for dopamine storage, leading to an accumulation of dopamine in the cytoplasm and increased levels of oxidative stress,. In this context, a mechanism involving iron in PD progression could result from the decrease of dopamine neurovesicles and the redistribution of highly oxidant iron-dopamine compounds in dopaminergic neurons. Using synchrotron X-ray chemical nano-imaging it will now be possible to study iron distribution in cellular models of PD dopaminergic neurons, and more generally, to investigate the subcellular distribution of any metal ion involved either in neurodegenerative diseases, or in physiological neuronal functions.
Synchrotron X-ray fluorescence chemical nano-imaging
Synchrotron undulator radiation is focused efficiently using dynamically bent graded multilayers set in the Kirkpatrick-Baez geometry. While this geometry is classical in X-ray optics, it is here extended, in combination with one of the world most brilliant X-ray sources, to an unprecedented spatial resolution and photon density. Both properties are however required for quantitative mapping of trace elements at the sub-cellular level. The spatial extent of the nanoprobe is below 90 nm in both directions. The experiments were conducted on a long, coherent beamline (ID19) and on a shorter beamline using the concept of a secondary source (the nano-imaging facility ID22NI). The first mirror of the X-ray optical device, coated with a graded multilayer, plays both the role of vertical focusing device and monochromator, resulting in a very high and unique X-ray flux (a few 1012 photons/s) at energies between 15 and 17 keV. The sample, mounted in air on a piezo nano-positioner stage, is scanned through the focal plane while the spectrum of the emitted fluorescence is recorded with an energy dispersive Si(Li) detector. The integration time per scan point was varied in the range 300 ms–1 s and kept below the onset of structural radiation damage as verified by repetitive sampling of the same specimen region.
Quantitative mapping of iron distribution
The X-ray fluorescence recorded spectra are fitted to obtain quantitative maps of the elements expressed in nanograms per square centimeters. The analysis of a certified reference material (Micromatter 4016), consisting in a Zn thin film deposit of 63.3 µg/cm2±5%, enabled to calibrate the element concentrations. Iron concentrations in subcellular compartments (cell body, neurite outgrowths, and distal ends) were determined using PyMCA software which enables to extract data from selected zones of the scanned area, and to fit corresponding X-ray fluorescence spectra. Mean iron quantitative distributions and standard deviation of the mean in subcellular compartments were calculated for each culture condition.
Cell cultures and sample preparation
Rat pheochromocytoma PC12 cells were used as in vitro model of dopamine producing cells,. PC12 cells were routinely maintained in RPMI 1640 medium, 4.5 g/L glucose, 10% equine serum, 5% fetal bovine serum, 2 mM glutamine and 100 U/mL penicillin-streptomycin, at 37°C in a water-saturated atmosphere containing 5% CO2. All chemical and biochemical compounds were from Sigma. About 2.104 PC12 cells were split directly onto 2 cm diameter sample holders consisting in a 2 µm thin polycarbonate foils for synchrotron X-ray fluorescence nano-imaging, or micro-PIXE (particle induced X-ray emission) analysis. Cells were allowed to differentiate with 100 ng/mL nerve growth factor and exposed to 300 µM FeSO4 during 24 h, to 1 mM AMT during 96 h, or to both compounds. These AMT and iron concentrations were found sub-cytotoxic as verified on separate experiments by cell counting assays. After appropriate exposure times, PC12 cells were rinsed with phosphate buffer solution, cryofixed at −160°C by plunge freezing into isopentane chilled with liquid nitrogen, and freeze dried at −35°C. This protocol was applied to maintain cellular morphology and chemical element distribution integrity.
Particle induced X-ray emission (PIXE)
Micro-PIXE analysis was performed to obtain quantitative element concentrations on groups of several hundred cells on the same samples to complete synchrotron X-ray fluorescence nano-imaging of single cells. PIXE and Rutherford Backscattering Spectrometry (RBS) were performed simultaneously using the nuclear microprobe beamline at the Centre d'Etudes Nucléaires de Bordeaux Gradignan (CENBG), France. The nuclear microprobe enables quantitative chemical analysis of trace elements in cells. In brief, the energy of the incident proton beam produced by the Van de Graaff accelerator was 2.5 MeV. The beam was focused onto the sample surface to a spot of 5 µm in diameter, resulting in a proton beam current of 250 pA as measured with a Faraday cup below the sample. X-ray fluorescence measurements were made with a Si(Li) energy dispersive detector placed at 45° from the incident beam direction. The RBS measurements were performed using a PIPS detector (passivated implanted planar silicon) placed at 135°. X-ray fluorescence data were analyzed with the Gupix software, used to compute X-ray attenuation within sample and variation in ionization and emission cross sections during slowing down of incoming particles. RBS data were analyzed with SIMNRA code and were used for mass normalization of X-ray emission leading to quantitative results expressed in terms of µg of element per g of sample.
Dopamine fluorescence microscopy
Dopamine fluorescence was observed immediately after freeze drying using an epifluorescence microscope (Olympus) with a combination of filters (U-MWU2) that coordinates excitation at 320–370 nm and allows observation of emission in the 420–600 nm range. Dopamine fluorescence was observed only in the case of cells exposed to an excess of iron. The observed fluorescence of dopamine is due to the formation of a fluorochrome compound after ring closure of dopamine. Oxidized catecholamines are fluorochromes with reported peak absorption and emission wavelengths respectively at 340–360 nm and 410–440 nm. In the case of dopamine, oxidized dopamine absorbs at 335 nm and emits fluorescence with a maximum at 470 nm which corresponds to the blue fluorescence observed in this study.
References 35
- 1.
Bossy-Wetzel E, Schwarzenbacher R, Lipton SA. Molecular pathways to neurodegeneration. Nature Med. 2004;10:S2-S9.
Not in our library10.1038/nm1067 (opens in a new tab)
- 2.
Gaeta A, Hider RC. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol. 2005;146:1041-1059.
Not in our library10.1038/sj.bjp.0706416 (opens in a new tab)
- 3.
Ke Y, Ming Qian Z. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol. 2003;2:246-53.
Not in our library10.1016/s1474-4422(03)00353-3 (opens in a new tab)
- 4.
Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nature Rev Neurosci. 2004;5:863-873.
Not in our library10.1038/nrn1537 (opens in a new tab)
- 5.
Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, et al. Increased nigral iron content in post-mortem parkinsonian brain. Lancet. 1987;2:1219-1220.
Not in our library10.1016/s0140-6736(87)91361-4 (opens in a new tab)
- 6.
Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem. 1989;52:515-520.
Not in our library10.1111/j.1471-4159.1989.tb09150.x (opens in a new tab)
- 7.
Griffiths PD, Dobson BR, Jones GR, Clarke DT. Iron in the basal ganglia in Parkinson's disease: an in vitro study using extended X-ray absorption fine strucutre and cryo-electron microscopy. Brain. 1999;122:667-673.
Not in our library10.1093/brain/122.4.667 (opens in a new tab)
- 8.
Ben Shachar B, Kahana N, Kampel V, Warshawsky A, Youdim MBH. Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacol. 2004;46:254-263.
Not in our library10.1016/j.neuropharm.2003.09.005 (opens in a new tab)
- 9.
Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, et al. Genetic or pharmacologic iron chelation prevents MPTP-induced neurotoxicity in vivo. A novel therapy for Parkinson's disease. Neuron. 2003;37:899-909.
Not in our library10.1016/s0896-6273(03)00126-0 (opens in a new tab)
- 10.
Linert W, Jameson GNL. Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's disease. J Inorg Biochem. 2000;79:319-326.
Not in our library10.1016/s0162-0134(99)00238-x (opens in a new tab)
- 11.
Paris I, Martinez-Alvarado P, Cardenas S, Perez-Pastene C, Graumann R. Dopamine-dependent iron toxicity in cells derived from rat hypothalamus. Chem Res Toxicol. 2005;18:415-419.
Not in our library10.1021/tx0497144 (opens in a new tab)
- 12.
Smythies J. The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion. Neurotox Res. 1999;1:27-39.
Not in our library10.1007/bf03033337 (opens in a new tab)
- 13.
Ortega R, Bohic S, Tucoulou R, Somogyi A, Devès G. Microchemical element imaging of yeast and human cells using synchrotron x-ray microprobe with Kirkpatrick-Baez optics. Anal Chem. 2004;76:309-314.
Not in our library10.1021/ac035037r (opens in a new tab)
- 14.
Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA. 1976;73:2424-2428.
Not in our library10.1073/pnas.73.7.2424 (opens in a new tab)
- 15.
Tischler AS, Greene LA. Morphologic and cytochemical properties of a clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Lab Invest. 1978;39:77-89.
Not in our library
- 16.
Falck B, Hillarp NA, Thieme G, Torp A. Fluorescence of catechol amines and related compounds condensed with formaldhehyde. J Histochem Cytochem. 1962;10:348-354.
Not in our library10.1016/0361-9230(82)90113-7 (opens in a new tab)
- 17.
Clarke SJ, Hollmann CA, Zhang Z, Suffern D, Bradforth SE et al. Photophysics of dopamine-modified quantum dots and effects on biological systems. Nature Mat. 2006;5:409-418.
Not in our library10.1038/nmat1631 (opens in a new tab)
- 18.
Liu Y, Schweitzer ES, Nirenberg MJ, Pickel VM, Evans CJ et al. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J Cell Biol. 1994;127:1419-1433.
Not in our library10.1083/jcb.127.5.1419 (opens in a new tab)
- 19.
Zierold K, Schafer D, Pietruschka F. The element distribution in ultrathin cryosections of cultivated fibroblast cells. Histochem. 1984;80:333-337.
Not in our library10.1007/bf00495413 (opens in a new tab)
- 20.
Ortega R, Moretto P, Fajac A, Bénard J, Llabador Y, et al. Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells. Cell Mol Biol. 1996;42:77-88.
Not in our library
- 21.
Eide DJ. Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta. 2006;1763:711-722.
Not in our library10.1016/j.bbamcr.2006.03.005 (opens in a new tab)
- 22.
Galvani P, Colleoni M, Origgi M, Santagostino A. Mitochondrial toxicity of iron and the protective role of ferritin on dopaminergic PC12 cells. Toxicol In Vitro. 1995;9:365-368.
Not in our library10.1016/0887-2333(95)00031-3 (opens in a new tab)
- 23.
Reaney SH, Smith DR. Manganese oxidation state mediates toxicity in PC12 cells. Toxicol Appl Pharmacol. 2005;205:271-281.
Not in our library10.1016/j.taap.2004.10.013 (opens in a new tab)
- 24.
Quintana C, Bellefqih S, Laval JY, Guerquin-Kern JL, Wu TD, et al. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol. 2006;153:42-54.
Not in our library10.1016/j.jsb.2005.11.001 (opens in a new tab)
- 25.
Zhang P, Land W, Lee S, Juliani J, Lefman J, et al. Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism. J Struct Biol. 2005;150:144-153.
Not in our library10.1016/j.jsb.2005.01.007 (opens in a new tab)
- 26.
Rouault TA. Iron on the brain. Nature Genetics. 2001;28:299-300.
Not in our library10.1038/91036 (opens in a new tab)
- 27.
Hirsch E, Graybiel AM, Agid YA. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature. 1988;334:345-348.
Not in our library10.1038/334345a0 (opens in a new tab)
- 28.
Kastner A, Hirsch EC, Agid Y, Javoy-Agid F. Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease. Brain Res. 1993;606:341-345.
Not in our library10.1016/0006-8993(93)91005-d (opens in a new tab)
- 29.
Mori F, Nishie M, Kakita A, Yoshimoto M, Takahashi H, et al. Relationship among alpha-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra. J Neuropathol Exp Neurol. 2006;65:808-815.
Not in our library10.1097/01.jnen.0000230520.47768.1a (opens in a new tab)
- 30.
Lotharius J, Brundin P. Pathogenesis of Parkinson's disease, dopamine, vesicles, and α-synuclein. Nature Rev Neurosci. 2002;3:932-942.
Not in our library10.1038/nrn983 (opens in a new tab)
- 31.
Lashuel HA, Hirling H. Rescuing defective vesicular trafficking protects against alpha-synuclein toxicity in cellular and animal models of Parkinson's disease. ACS Chem Biol. 2006;1:420-4.
Not in our library10.1021/cb600331e (opens in a new tab)
- 32.
Hignette O, Cloetens P, Rostaing G, Bernard P, Morawe C. Efficient sub 100 nm focusing of hard x rays. Rev Sci Instrum. 2005;76:063709.
Not in our library
- 33.
Kirkpatrick P, Baez AV. Formation of optical images by X-rays. J Opt Soc Am. 1948;38:766-774.
Not in our library10.1364/josa.38.000766 (opens in a new tab)
- 34.
Bohic S, Simionovici A, Ortega R, Heymann D, Schroer C, et al. Synchrotron hard X-ray microprobe: fluorescence imaging of single cells. Appl Phys Letters. 2001;78:3544-3546.
Not in our library
- 35.
Solé VA, Papillon E, Cotte M, Walter Ph, Susini J. A multiplatform code for the analysis of energy-dispersive X-ray fluorescence spectra. Spectrochim Acta. 2007;B62:63-68.
Not in our library
Cited by papers we hold 1
Questions about this paper
We email you if it is retracted, withdrawn, corrected or flagged.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.